Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bexxar Retreatment, Leukemia Reports Among Corixa’s Phase IV Studies

Jul 07 2003

• By The Pink Sheet

Related Content

GSK/Corixa Bexxar Nuclear Pharmacy Training Kicks Off With FDA Approval

Jul 07 2003

Corixa/GSK Will Submit Bexxar-Zevalin Trial Protocol To FDA In January

Dec 23 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window